AOA
0.003
50%
BOC
0.575
-50%
BUY
0.003
50%
TR2
0.34
-44.3%
ENL
0.033
43.5%
BLZ
0.002
-33.3%
ALM
0.007
40%
1AD
0.003
-25%
FBR
0.004
33.3%
C7A
0.003
-25%
AAU
0.01
25%
CTN
0.003
-25%
AUR
0.02
25%
RLC
0.003
-25%
MTM
0.855
24.8%
M2M
0.013
-23.5%
LM1
0.185
23.3%
IS3
0.018
-21.7%
SPQ
0.011
22.2%
EPM
0.015
-21.1%
PHX
0.14
21.7%
NFM
0.02
-20%
NHE
0.045
21.6%
OEL
0.004
-20%
PLC
0.006
20%
FMR
0.275
-16.7%
SHN
0.02
17.6%
KOB
0.06
-16.7%
AS2
0.014
16.7%
DY6
0.115
-14.8%
SIO
0.14
16.7%
MGU
0.006
-14.3%
ATC
0.029
16%
WLD
0.012
-14.3%
RLF
0.074
15.6%
ZMM
0.006
-14.3%
IMI
0.015
15.4%
HWK
0.025
-13.8%
PTX
0.062
14.8%
NVQ
0.02
-13%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf